Suppr超能文献

[1例晚期胃癌伴腹膜播散经单用S-1四线化疗有效治疗的病例]

[A case of advanced gastric cancer with peritoneal dissemination effectively treated with fourth-line chemotherapy of S-1 alone].

作者信息

Murakami Soichiro, Samejima Ryuichiro, Sumi Kenji, Hidaka Katsuhiko

机构信息

Dept. of Surgery, Takeo City Hospital.

出版信息

Gan To Kagaku Ryoho. 2007 Jun;34(6):915-8.

Abstract

The patient was a 42-year-old female diagnosed with unresectable highly advanced gastric cancer complicated by peritoneal dissemination. We performed systemic chemotherapy with MTX+5-FU as the first-line treatment, which stabilized the disease. Since the patient initially wished a radical resection, we tried chemotherapy with weekly PTX as a second-line treatment. Her therapeutic response remained between a partial response and a stable disease for about five months, followed, however, by progressive disease. The result of the third-line treatment with CPT-11+CDDP was again a progressive disease, so we switched her regimen to single-agent S-1 as a fourth-line treatment. The ascites disappeared three months after the change in regimen. As of March 2006, the patient had survived for 17 months since diagnosis (8 months since the ongoing S-1 therapy started) and the disease is currently stabilized, and preserving a favorable performance status. However, in June 2006, the patient died of pneumonia 20 months after the diagnosis.

摘要

该患者为一名42岁女性,被诊断为无法切除的高度进展期胃癌并伴有腹膜播散。我们采用MTX + 5 - FU进行全身化疗作为一线治疗,病情得以稳定。由于患者最初希望进行根治性切除,我们尝试使用每周一次的紫杉醇(PTX)进行化疗作为二线治疗。她的治疗反应在部分缓解和病情稳定之间维持了约五个月,但随后病情进展。使用伊立替康(CPT - 11)+顺铂(CDDP)进行三线治疗的结果仍是病情进展,因此我们将她的治疗方案改为单药S - 1作为四线治疗。方案改变三个月后腹水消失。截至2006年3月,患者自确诊以来已存活17个月(自开始进行当前的S - 1治疗起8个月),目前病情稳定,身体状况良好。然而,2006年6月,该患者在确诊20个月后死于肺炎。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验